Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis

Fig. 3

Kaplan Meier survival analysis of Ep-ICD in Oral Dysplasia and OSCC patients. a Dysplasia patients with increased overall (nuclear and cytoplasmic) Ep-ICD score had significantly reduced mean cancer free survival of 47 months as compared to patients with low overall Ep-ICD score (mean cancer free survival = 57.5 months; p = 0.044); b OSCC patients with increased Ep-ICDNuc and EpExMem score had significantly reduced mean disease free survival (DFS) of 33.7 months as compared to patients with decreased Ep-ICDNuc and EpExMem score (mean DFS = 46.3 months; p = 0.018)

Back to article page